Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-01-02 @ 6:11 AM
Study NCT ID:
NCT03237832
Status:
COMPLETED
Last Update Posted:
2017-08-03
First Post:
2017-07-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of ARN-6039
Sponsor:
Arrien Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-21
First Submit QC Date:
None
Study First Post Date:
2017-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-02
Last Update Post Date:
2017-08-03
Last Update Post Date Type:
ACTUAL